Jamjoom Pharmaceuticals Factory Co. Announces the Results of the Extraordinary General Assembly Meeting (First Meeting)

Element List	Explanation
Introduction	The Board of Directors of Jamjoom Pharmaceuticals Factory Company (the “Company”) is pleased to announce the results of the Extraordinary General Assembly (First Meeting) held on Monday 15/06/2026G corresponding to 29/12/1447H after the quorum for the validity of the meeting was completed.
City and Location of the General Assembly's Meeting	Jeddah – Sari Street – Company headquarters – via modern technology means (using Tadawulaty system).
Date of the General Assembly's Meeting	2026-06-15 Corresponding to 1447-12-29
Time of the General Assembly’s Meeting	20:30
Percentage of Attending Shareholders	85.0%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	The meeting was attended by the following Board Members:

1- Mr. Mahmoud Yousuf Jamjoom (Chairman)

2- Mr. Ahmed Yousuf Jamjoom (Vice Chairman)

3- Mr. Mohammed Yousuf Jamjoom (Member)

4- Mr. Waleed Yousuf Jamjoom (Member)

5- Mrs. Alaa Yousuf Jamjoom (Member)

6- Mr. Faris Ibrahim Al Ghannam (Member)

7- Mr. Javed Ghulam Mohammad (Member)

8- Mr. Benjamin Richard Toogood (Member)

The following member was unable to attend this meeting:

Mr. Noor Ahmed Kather Pasha Sheriff (Member) Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf Names of the Chairmen of the Committees present at the meeting or members of such Committees attending on their behalf:

Mr. Faris Ibrahim Abdullah Al Ghannam (Chairman of the Audit Committee).

Mrs. Rania Sami Al-Turki (Chairman of the Nomination and Remuneration Committee)

Mr. Benjamin Richard Toogood (Chairman of the Executive Committee) Voting Results on the Items of the General Assembly's Meeting Agenda's Please Check the attached document Additional Information For any inquiries, please directly contact the Investor Relations Department through:

Email:

IR@jamjoompharma.com Attached Documents

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.